Ambitious goals in autoimmune research
Sanger Excellence Fellow Dr Samantha Jumbe aims to understand the role of genetic mutations in autoimmune conditions like lupus, psoriasis and systemic liver disease.
Unravelling how parasitic worms respond to drug treatment
Parasitic worms transmitted through the soil infect an estimated 1.5 billion people worldwide and cause diseases that help drive poverty in tropical and subtropical countries. Wellcome Sanger Institute researchers, as part of the STOP2030 project, are using their unique genetics expertise to monitor the effects of promising new treatments to help combat these diseases.
Studying cancer and pre-cancer in Latin America
New research is focussing on understanding the genetic causes of acral melanoma - an understudied disease that is the most common type of melanoma in Mexico.
Digital transformation and a new era in science
Digital technologies are rapidly evolving. James McCafferty, Chief Information Officer at the Wellcome Sanger Institute, discusses the latest opportunities and challenges for research, including generative AI and enhanced data science.
Hope for tackling deadly bacterial disease
The fight against melioidosis - a neglected, often fatal, bacterial disease.
Faster, effective and safer gene engineering
Meet Valentina Migliori, a researcher working to make lab science more relevant to clinical research.
Genomics gets faster, cheaper, and more accurate
Four new platforms have been added to one of the world’s largest genome sequencing facilities at the Wellcome Sanger Institute. increasing the speed, capacity and precision of DNA and RNA sequencing.
Meet Professor Tulio de Oliveira, forging a genomic surveillance partnership
As head of the largest genomics institute in Africa and the Genomic Surveillance Unit’s new deputy director, Professor Tulio de Oliveira hopes close collaboration can be “world changing.”
From bench to bedside – Innovating blood cancer clinical practice
We spoke to Jyoti Nangalia, a researcher at the forefront of innovation in blood cancers. She is combining her clinical and academic expertise to bring better diagnosis tools for patients and clinicians.
